Answers are grounded in this paper and cite their sources.
In this study, a series of eight 1,2,4-triazole-based hept-6-ene-1,3,5-trione analogues (AM-1-8) was designed and synthesized by combining a triazole-bearing aromatic group with a curcuminoid-inspired triketone framework. The compounds were obtained through a key triketone intermediate followed by Claisen-Schmidt condensation with appropriately substituted aromatic aldehydes, yielding the final products in the range of 49-81%. Structural characterization was performed using infrared spectroscopy, nuclear magnetic resonance and mass spectrometry. Molecular docking against COX-2 (PDB: 3NT1) and computational ADMET and toxicity profiling using SwissADME and ProTox-II were undertaken as preliminary assessments of their pharmacological properties. Compound AM-6 bearing an o-hydroxyphenyl substituent, received the most favourable docking score (-8.7 kcal/mol). The anti-inflammatory activity of the synthesized analogues was investigated in vivo using the carrageenan-induced paw edema model in Wistar rats, with diclofenac sodium as the reference drug. All eight analogues exhibited lower paw volumes than the disease control at the later observation time points. Compound AM-6 recorded the lowest paw volume (4.05) at 150 min, compared with 4.80 for diclofenac sodium. ProTox-II predictions revealed potential toxicity-related liabilities, precluding any preliminary claim of safety.
No takes yet. Share an insight, caveat, or question.
Katore et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: